Importance of Aggressive Blood Pressure Lowering When It May Matter Most

American Journal of Cardiology

Volumn 100, Issue 3 SUPPL., 2007, Pages

  White, William B ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM ANTAGONIST; HYDROCHLOROTHIAZIDE; LONG ACTING DRUG; PLACEBO; RAMIPRIL; SHORT ACTING DRUG; TELMISARTAN; VALSARTAN;

ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HUMAN; HYPERTENSION; MORBIDITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TREATMENT DURATION; WHITE COAT HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DECISION TREES; HUMANS; HYPERTENSION;

EID: 34547112553     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.05.009     Document Type: Article

References (45)

1. White W.B. Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med 348 (2003) 2377-2378
2. Pickering T.G., James G.D., Boddie C., Harshfield G.A., Blank S., and Laragh J.H. How common is white coat hypertension?. JAMA 259 (1988) 225-228
3. Lerman C.E., Brody D.S., Hui T., Lazaro C., Smith D.G., and Blum M.J. The white-coat hypertension response: prevalence and predictors. J Gen Intern Med 4 (1989) 226-231
4. Pierdomenico S.D., Mezzetti A., Lapenna D., Guglielmi M.D., Mancini M., Salvatore L., Antidormi T., Costantini F., and Cuccurullo F. 'White-coat' hypertension in patients with newly diagnosed hypertension: evaluation of prevalence by ambulatory monitoring and impact on cost of health care. Eur Heart J 16 (1995) 692-697
5. Selenta C., Hogan B.E., and Linden W. How often do office blood pressure measurements fail to identify true hypertension?. An exploration of white-coat normotension. Arch Fam Med 9 (2000) 533-540
6. Mancia G. Blood pressure variability at normal and high blood pressure. Chest 83 (1983) 317-320
7. Millar-Craig M.W., Bishop C.N., and Raftery E.B. Circadian variation of blood-pressure. Lancet 1 (1978) 795-797
8. Eguchi K., Kario K., and Shimada K. Comparison of candesartan with lisinopril on ambulatory blood pressure and morning surge in patients with systemic hypertension. Am J Cardiol 92 (2003) 621-624
9. O'Brien E., Sheridan J., and O'Malley K. Dippers and non-dippers. Lancet 2 (1988) 397
10. Izzedine H., Launay-Vacher V., and Deray G. Abnormal blood pressure circadian rhythm: a target organ damage?. Int J Cardiol 107 (2006) 343-349
11. Muller J.E., Stone P.H., Turi Z.G., Rutherford J.D., Czeisler C.A., Parker C., Poole W.K., Passamani E., Roberts R., Robertson T., et al., MILIS Study Group. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 313 (1985) 1315-1322
12. Baliga R.R., Rosen S.D., Camici P.G., and Kooner J.S. Regional myocardial blood flow redistribution as a cause of postprandial angina pectoris. Circulation 97 (1998) 1144-1149
13. Marler J.R., Price T.R., Clark G.L., Muller J.E., Robertson T., Mohr J.P., Hier D.B., Wolf P.A., Caplan L.R., and Foulkes M.A. Morning increase in onset of ischemic stroke. Stroke 20 (1989) 473-476
14. Elliott W.J. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 29 (1998) 992-996
15. Willich S.N., Levy D., Rocco M.B., Tofler G.H., Stone P.H., and Muller J.E. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 60 (1987) 801-806
16. Taylor C.R., Hodge E.M., White D.A., and Amlodipine Angina Study Group. Circadian rhythm of angina: similarity to circadian rhythms of myocardial infarction, ischemic ST segment depression, and sudden cardiac death. Am Heart J 118 (1989) 1098-1099
17. Rocco M.B., Barry J., Campbell S., Nabel E., Cook E.F., Goldman L., and Selwyn A.P. Circadian variation of transient myocardial ischemia in patients with coronary artery disease. Circulation 75 (1987) 395-400
18. Mulcahy D., Keegan J., Cunningham D., Quyyumi A., Crean P., Park A., Wright C., and Fox K. Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet 2 (1988) 755-759
19. Ogawa H., Yasue H., Oshima S., Okumura K., Matsuyama K., and Obata K. Circadian variation of plasma fibrinopeptide A level in patients with variant angina. Circulation 80 (1989) 1617-1626
20. White W.B. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit 2 (1997) 47-51
21. Veerman D.P., Imholz B.P., Wieling W., Wesseling K.H., and van Montfrans G.A. Circadian profile of systemic hemodynamics. Hypertension 26 (1995) 55-59
22. Tofler G.H., Brezinski D., Schafer A.I., Czeisler C.A., Rutherford J.D., Willich S.N., Gleason R.E., Williams G.H., and Muller J.E. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 316 (1987) 1514-1518
23. Manfredini R., Gallerani M., Portaluppi F., and Fersini C. Relationships of the circadian rhythms of thrombotic, ischemic, hemorrhagic, and arrhythmic events to blood pressure rhythms. Ann N Y Acad Sci 783 (1996) 141-158
24. Kunita H., Obara T., Komatsu T., Hata S., and Okamoto M. The effects of dietary sodium on the diurnal activity of the renin-angiotensin-aldosterone system and the excretion of urinary electrolytes. J Clin Endocrinol Metab 43 (1976) 756-759
25. Prinz P.N., Halter J., Benedetti C., and Raskind M. Circadian variation of plasma catecholamines in young and old men: relation to rapid eye movement and slow wave sleep. J Clin Endocrinol Metab 49 (1979) 300-304
26. Katz F.H., Romfh P., and Smith J.A. Diurnal variation of plasma aldosterone, cortisol and renin activity in supine man. J Clin Endocrinol Metab 40 (1975) 125-134
27. Mulcahy D. Circadian variation in cardiovascular events. Blood Press Monit 3 (1998) 29-34
28. Kario K., Eguchi K., Umeda Y., Hoshide S., Hoshide Y., Morinari M., Murata M., Kuroda T., Shimada K., Pickering T.G., and Schwartz J.E. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. Circulation 108 (2003) e72-e73
29. Imai Y., Ohkubo T., Sakuma M., Tsuji I.I., Satoh H., Nagai K., Hisamichi S., and Abe K. Predictive power of screening blood pressure, ambulatory blood pressure and blood pressure measured at home for overall and cardiovascular mortality: a prospective observation in a cohort from Ohasama, northern Japan. Blood Press Monit 1 (1996) 251-254
30. Staessen J.A., Thijs L., Fagard R., O'Brien E.T., Clement D., de Leeuw P.W., Mancia G., Nachev C., Palatini P., Parati G., Tuomilehto J., and Webster J. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA 282 (1999) 539-546
31. Clement D.L., De Buyzere M.L., De Bacquer D.A., de Leeuw P.W., Duprez D.A., Fagard R.H., Gheeraert P.J., Missault L.H., Braun J.J., Six R.O., Van Der N.P., and O'Brien E. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 348 (2003) 2407-2415
32. Sega R., Facchetti R., Bombelli M., Cesana G., Corrao G., Grassi G., and Mancia G. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 111 (2005) 1777-1783
33. Verdecchia P., Reboldi G.P., Angeli F., Schillaci G., Schwartz J.E., Pickering T.G., Imai Y., Ohkubo T., and Kario K. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 45 (2005) 203-208
34. Redón J., Roca-Cusachs A., and Mora-Macia J. Uncontrolled early morning blood pressure in medicated patients: the ACAMPA study. Analysis of the control of blood pressure using ambulatory blood pressure monitoring. Blood Press Monit 7 (2002) 111-116
35. Mengden T., Binswanger B., Spuhler T., Weisser B., and Vetter W. The use of self-measured blood pressure determinations in assessing dynamics of drug compliance in a study with amlodipine once a day, morning versus evening. J Hypertens 11 (1993) 1403-1411
36. 1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 15 (1998) 206-217
37. Lacourcière Y., Lenis J., Orchard R., Lewanczuk R., Houde M., Pesant Y., Wright J., Wilson T., and Martin K. A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit 3 (1998) 295-302
38. Williams B., Gosse P., Lowe L., Harper R., and PRISMA I Study Group. The Prospective, Randomized Investigation of the Safety and Efficacy of Telmisartan versus Ramipril Using Ambulatory Blood Pressure Monitoring (PRISMA I). J Hypertens 24 (2006) 193-200
39. Lacourcière Y., Neutel J.M., Davidai G., and Koval S. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Am J Hypertens 19 (2006) 104-112
40. Gosse P., Neutel J.M., Schumacher H., Lacourcière Y., Williams B., and Davidai G. The effect of the telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials. Blood Press Monit 12 (2007) 141-147
41. Chobanian A.V., Bakris G.L., Black H.R., Cushman W.C., Green L.A., Izzo Jr. J.L., Jones D.W., Materson B.J., Oparil S., Wright Jr. J.T., and Roccella E.J. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289 (2003) 2560-2572
42. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21 (2003) 1011-1053
43. White W.B., Punzi H.A., Murwin D., Koval S.E., Davidai G., and Neutel J.M. Effects of the angiotensin II receptor blockers telmisartan vs valsartan in combination with hydrochlorothiazide 25 mg once daily for the treatment of hypertension. J Clin Hypertens (Greenwich) 8 (2006) 626-633
44. White W.B., Giles T., Bakris G.L., Neutel J.M., Davidai G., and Weber M.A. Measuring the efficacy of antihypertensive therapy by ambulatory blood pressure monitoring in the primary care setting. Am Heart J 151 (2006) 176-184
45. White W.B., Weber M.A., Davidai G., Neutel J.M., Bakris G.L., and Giles T. Ambulatory blood pressure monitoring in the primary care setting: assessment of therapy on the circadian variation of blood pressure from the MICCAT-2 Trial. Blood Press Monit 10 (2005) 157-163